Cargando…

Changes in peripheral T-lymphocyte subsets and serum cytokines in patients with systemic sclerosis

Objective: T cells represent a predominant cell type in autoimmune disease. However, their exact roles are not fully clear in systemic sclerosis (SSc). This study aimed to mainly investigate the alteration in the absolute numbers of T-lymphocyte subsets and the serum levels of cytokines in SSc patie...

Descripción completa

Detalles Bibliográficos
Autores principales: Guo, Rong-Hong, Cheng, Hao, Zhang, Xiao-Ying, Yu, Zhen, Wang, Guang-Hui, Hao, Shu-Ya, Gao, Xiao-Peng, Wen, Hong-Yan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9669295/
https://www.ncbi.nlm.nih.gov/pubmed/36408259
http://dx.doi.org/10.3389/fphar.2022.986199
_version_ 1784832067174924288
author Guo, Rong-Hong
Cheng, Hao
Zhang, Xiao-Ying
Yu, Zhen
Wang, Guang-Hui
Hao, Shu-Ya
Gao, Xiao-Peng
Wen, Hong-Yan
author_facet Guo, Rong-Hong
Cheng, Hao
Zhang, Xiao-Ying
Yu, Zhen
Wang, Guang-Hui
Hao, Shu-Ya
Gao, Xiao-Peng
Wen, Hong-Yan
author_sort Guo, Rong-Hong
collection PubMed
description Objective: T cells represent a predominant cell type in autoimmune disease. However, their exact roles are not fully clear in systemic sclerosis (SSc). This study aimed to mainly investigate the alteration in the absolute numbers of T-lymphocyte subsets and the serum levels of cytokines in SSc patients. Methods: A total of 76 patients with SSc and 76 age- and sex-matched healthy controls (HCs) were enrolled. The levels of circulating T cell subsets and serum cytokines were measured by flow cytometry. T cell subsets or serum cytokines correlations with disease activity and organ involvement were analyzed. Results: The absolute numbers of Th2 and Treg cells in SSc patients were lower than those in HCs (p < 0.05), resulting in the ratios of Th1/Th2 [25.01 (12.24, 38.61) vs. 11.64 (6.38, 20.34)] and Th17/Treg [0.42 (0.17, 0.66) vs. 0.17 (0.13, 0.29)] were increased significantly (p < 0.001). The absolute numbers of total T, Th, and Treg cells were negatively correlated with CRP (r = -0.406, p = 0.002; r = -0.263, p < 0.05; r = -0.367 p < 0.01). The serum levels of IL-2, SIL-2R, IL-6, IL-10, INF-γ, and TNF-α were significantly higher than those in HCs (p < 0.001). Increasing IL-2 in the wake of the augment of ESR (r = 0.671, p = 0.004), so did IL-6 (r = 0.378, p < 0.05). The ratio of Th17/Treg in SSc-ILD patients had lower levels than that in other patients [0.35 (0.14, 0.53) vs. 0.64 (0.26, 0.93) p = 0.028]; Treg cells were lessened in patients with Raynaud’s phenomenon relative to controls [3.00 (2.41, 4.28) vs. 3.55 (2.86, 4.53) p < 0.05]. The levels of IL-2, IL-10 and INF-γ [3.32 (1.05,11.73) vs. 2.32 (0.44,6.45), p = 0.045], [8.08 (3.63, 355,77) vs. 4.89 (0.78, 21.44), p = 0.02], [6.31 (2.66, 44.03) vs. 4.03 (0.22, 16.96), p = 0.009] were elevated in patients with arthralgia, while the level of Th17 was decreased [0.62 (0.20,2.16) vs. 1.26 (0.22,10.93), p = 0.026]. ROC curve analysis yielded an optimal cut-off IL-2, IL-10, and INF-γ levels of 2.67, 5.93, and 5.32 pg/ml for the presence of arthralgia. Conclusion: We exhibited abnormalities in T subsets and the production of their cytokines in SSc, as compared with those in HCs. This may allow the pathogenesis of SSc and the development of novel therapeutic interventions aimed at targeting these cells and the cytokines they produce.
format Online
Article
Text
id pubmed-9669295
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-96692952022-11-18 Changes in peripheral T-lymphocyte subsets and serum cytokines in patients with systemic sclerosis Guo, Rong-Hong Cheng, Hao Zhang, Xiao-Ying Yu, Zhen Wang, Guang-Hui Hao, Shu-Ya Gao, Xiao-Peng Wen, Hong-Yan Front Pharmacol Pharmacology Objective: T cells represent a predominant cell type in autoimmune disease. However, their exact roles are not fully clear in systemic sclerosis (SSc). This study aimed to mainly investigate the alteration in the absolute numbers of T-lymphocyte subsets and the serum levels of cytokines in SSc patients. Methods: A total of 76 patients with SSc and 76 age- and sex-matched healthy controls (HCs) were enrolled. The levels of circulating T cell subsets and serum cytokines were measured by flow cytometry. T cell subsets or serum cytokines correlations with disease activity and organ involvement were analyzed. Results: The absolute numbers of Th2 and Treg cells in SSc patients were lower than those in HCs (p < 0.05), resulting in the ratios of Th1/Th2 [25.01 (12.24, 38.61) vs. 11.64 (6.38, 20.34)] and Th17/Treg [0.42 (0.17, 0.66) vs. 0.17 (0.13, 0.29)] were increased significantly (p < 0.001). The absolute numbers of total T, Th, and Treg cells were negatively correlated with CRP (r = -0.406, p = 0.002; r = -0.263, p < 0.05; r = -0.367 p < 0.01). The serum levels of IL-2, SIL-2R, IL-6, IL-10, INF-γ, and TNF-α were significantly higher than those in HCs (p < 0.001). Increasing IL-2 in the wake of the augment of ESR (r = 0.671, p = 0.004), so did IL-6 (r = 0.378, p < 0.05). The ratio of Th17/Treg in SSc-ILD patients had lower levels than that in other patients [0.35 (0.14, 0.53) vs. 0.64 (0.26, 0.93) p = 0.028]; Treg cells were lessened in patients with Raynaud’s phenomenon relative to controls [3.00 (2.41, 4.28) vs. 3.55 (2.86, 4.53) p < 0.05]. The levels of IL-2, IL-10 and INF-γ [3.32 (1.05,11.73) vs. 2.32 (0.44,6.45), p = 0.045], [8.08 (3.63, 355,77) vs. 4.89 (0.78, 21.44), p = 0.02], [6.31 (2.66, 44.03) vs. 4.03 (0.22, 16.96), p = 0.009] were elevated in patients with arthralgia, while the level of Th17 was decreased [0.62 (0.20,2.16) vs. 1.26 (0.22,10.93), p = 0.026]. ROC curve analysis yielded an optimal cut-off IL-2, IL-10, and INF-γ levels of 2.67, 5.93, and 5.32 pg/ml for the presence of arthralgia. Conclusion: We exhibited abnormalities in T subsets and the production of their cytokines in SSc, as compared with those in HCs. This may allow the pathogenesis of SSc and the development of novel therapeutic interventions aimed at targeting these cells and the cytokines they produce. Frontiers Media S.A. 2022-11-03 /pmc/articles/PMC9669295/ /pubmed/36408259 http://dx.doi.org/10.3389/fphar.2022.986199 Text en Copyright © 2022 Guo, Cheng, Zhang, Yu, Wang, Hao, Gao and Wen. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Pharmacology
Guo, Rong-Hong
Cheng, Hao
Zhang, Xiao-Ying
Yu, Zhen
Wang, Guang-Hui
Hao, Shu-Ya
Gao, Xiao-Peng
Wen, Hong-Yan
Changes in peripheral T-lymphocyte subsets and serum cytokines in patients with systemic sclerosis
title Changes in peripheral T-lymphocyte subsets and serum cytokines in patients with systemic sclerosis
title_full Changes in peripheral T-lymphocyte subsets and serum cytokines in patients with systemic sclerosis
title_fullStr Changes in peripheral T-lymphocyte subsets and serum cytokines in patients with systemic sclerosis
title_full_unstemmed Changes in peripheral T-lymphocyte subsets and serum cytokines in patients with systemic sclerosis
title_short Changes in peripheral T-lymphocyte subsets and serum cytokines in patients with systemic sclerosis
title_sort changes in peripheral t-lymphocyte subsets and serum cytokines in patients with systemic sclerosis
topic Pharmacology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9669295/
https://www.ncbi.nlm.nih.gov/pubmed/36408259
http://dx.doi.org/10.3389/fphar.2022.986199
work_keys_str_mv AT guoronghong changesinperipheraltlymphocytesubsetsandserumcytokinesinpatientswithsystemicsclerosis
AT chenghao changesinperipheraltlymphocytesubsetsandserumcytokinesinpatientswithsystemicsclerosis
AT zhangxiaoying changesinperipheraltlymphocytesubsetsandserumcytokinesinpatientswithsystemicsclerosis
AT yuzhen changesinperipheraltlymphocytesubsetsandserumcytokinesinpatientswithsystemicsclerosis
AT wangguanghui changesinperipheraltlymphocytesubsetsandserumcytokinesinpatientswithsystemicsclerosis
AT haoshuya changesinperipheraltlymphocytesubsetsandserumcytokinesinpatientswithsystemicsclerosis
AT gaoxiaopeng changesinperipheraltlymphocytesubsetsandserumcytokinesinpatientswithsystemicsclerosis
AT wenhongyan changesinperipheraltlymphocytesubsetsandserumcytokinesinpatientswithsystemicsclerosis